These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38166671)

  • 1. Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm.
    Rao SS; Manabe N; Karasawa Y; Hasebe Y; Nozawa K; Nakajima A; Fukudo S
    BMC Gastroenterol; 2024 Jan; 24(1):12. PubMed ID: 38166671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.
    Black CJ; Burr NE; Quigley EMM; Moayyedi P; Houghton LA; Ford AC
    Gastroenterology; 2018 Dec; 155(6):1753-1763. PubMed ID: 30144426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
    Eguchi T; Yoshizaki T; Ikeoka S; Takagi M; Fujinami M; Matsuda T; Yamaguchi T; Nonaka T; Amioka S; Katayama N; Inoue K; Matsumoto M; Momose K; Sako T; Noda M; Morisawa T; Okada A
    Dig Dis; 2021; 39(4):341-350. PubMed ID: 33142288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.
    Huang H; Taylor DC; Carson RT; Sarocco P; Friedman M; Munsell M; Blum SI; Menzin J
    J Med Econ; 2015 Apr; 18(4):283-94. PubMed ID: 25333331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan.
    Nakajima A; Shoji A; Kokubo K; Igarashi A
    Gastroenterol Res Pract; 2021; 2021():5534687. PubMed ID: 34887919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study.
    Ooba N; Takahashi Y; Nagamura M; Takahashi M; Ushida M; Kawakami E; Kimura M; Sato T; Tokuyoshi J; Miyazaki C; Shimada M
    Expert Opin Drug Saf; 2021 Dec; 20(12):1553-1558. PubMed ID: 34281471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review with meta-analysis: lubiprostone efficacy on the treatment of patients with constipation.
    Passos MDCF; Takemoto MLS; Corradino GC; Guedes LS
    Arq Gastroenterol; 2020; 57(4):498-506. PubMed ID: 33331483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.
    Atluri DK; Chandar AK; Bharucha AE; Falck-Ytter Y
    Neurogastroenterol Motil; 2014 Apr; 26(4):499-509. PubMed ID: 24351035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Suares NC
    Gut; 2011 Feb; 60(2):209-18. PubMed ID: 21205879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED; Kim HM; Schoenfeld P
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
    Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.
    Shah ED; Suresh S; Jou J; Chey WD; Stidham RW
    Am J Gastroenterol; 2020 Apr; 115(4):596-602. PubMed ID: 32022721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis.
    Nelson AD; Camilleri M; Chirapongsathorn S; Vijayvargiya P; Valentin N; Shin A; Erwin PJ; Wang Z; Murad MH
    Gut; 2017 Sep; 66(9):1611-1622. PubMed ID: 27287486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapies for constipation.
    Thayalasekeran S; Ali H; Tsai HH
    World J Gastroenterol; 2013 Dec; 19(45):8247-51. PubMed ID: 24363515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
    Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.
    Huang H; Taylor DC; Carson RT; Sarocco P; Friedman M; Munsell M; Blum SI; Menzin J
    Manag Care; 2016 Feb; 25(2):41-8. PubMed ID: 27008836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pharmacological treatment options for chronic constipation.
    Corsetti M; Tack J
    Expert Opin Pharmacother; 2014 May; 15(7):927-41. PubMed ID: 24661106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
    Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.